Christoph Rader, Ph.D. - Publications

Affiliations: 
2012 Scripps Research Institute 
 2003-2012 Experimental Transplantation and Immunology Branch NCI, Somers, CT, United States 

161 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Qi J, Hymel D, Nelson CG, Burke TR, Rader C. Conventional and Chemically Programmed Asymmetric Bispecific Antibodies Targeting Folate Receptor 1. Frontiers in Immunology. 10: 1994. PMID 31497024 DOI: 10.3389/fimmu.2019.01994  1
2019 Rader C, Wiestner A. Six-packed antibodies punch better. Haematologica. 104: 1696-1699. PMID 31473607 DOI: 10.3324/haematol.2019.224196  1
2019 Nanna AR, Rader C. Engineering Dual Variable Domains for the Generation of Site-Specific Antibody-Drug Conjugates. Methods in Molecular Biology (Clifton, N.J.). 2033: 39-52. PMID 31332746 DOI: 10.1007/978-1-4939-9654-4_4  1
2019 Hwang D, Nilchan N, Nanna AR, Li X, Cameron MD, Roush WR, Park H, Rader C. Site-Selective Antibody Functionalization via Orthogonally Reactive Arginine and Lysine Residues. Cell Chemical Biology. PMID 31231031 DOI: 10.1016/j.chembiol.2019.05.010  1
2018 Rydzek J, Nerreter T, Peng H, Jutz S, Leitner J, Steinberger P, Einsele H, Rader C, Hudecek M. Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell Platform. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 30573301 DOI: 10.1016/j.ymthe.2018.11.015  1
2018 Mage RG, Esteves PJ, Rader C. Rabbit models of human diseases for diagnostics and therapeutics development. Developmental and Comparative Immunology. PMID 30339876 DOI: 10.1016/j.dci.2018.10.003  0.32
2018 Wilson HD, Li X, Peng H, Rader C. A Sortase a Programmable Phage Display Format for Improved Panning of Fab Antibody Libraries. Journal of Molecular Biology. PMID 30213726 DOI: 10.1016/j.jmb.2018.09.003  1
2018 Qi J, Chen SS, Chiorazzi N, Rader C. An IgG1-like bispecific antibody targeting CD52 and CD20 for the treatment of B-cell malignancies. Methods (San Diego, Calif.). PMID 30145356 DOI: 10.1016/j.ymeth.2018.08.008  1
2018 Chang J, Peng H, Shaffer BC, Baskar S, Wecken IC, Cyr MG, Martinez GJ, Soden J, Freeth J, Wiestner A, Rader C. Siglec-6 on chronic lymphocytic leukemia cells is a target for post-allogeneic hematopoietic stem cell transplantation antibodies. Cancer Immunology Research. PMID 29980538 DOI: 10.1158/2326-6066.CIR-18-0102  1
2018 Qi J, Li X, Peng H, Cook EM, Dadashian EL, Wiestner A, Park H, Rader C. Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1. Proceedings of the National Academy of Sciences of the United States of America. PMID 29844189 DOI: 10.1073/pnas.1719905115  1
2018 Robinson HR, Qi J, Cook EM, Nichols C, Dadashian EL, Underbayev C, Herman SEM, Saba NS, Keyvanfar K, Sun C, Ahn IE, Baskar S, Rader C, Wiestner A. A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era. Blood. PMID 29743179 DOI: 10.1182/blood-2018-02-830992  1
2017 Nanna AR, Li X, Walseng E, Pedzisa L, Goydel RS, Hymel D, Burke TR, Roush WR, Rader C. Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates. Nature Communications. 8: 1112. PMID 29062027 DOI: 10.1038/s41467-017-01257-1  1
2017 Peng H, Nerreter T, Chang J, Qi J, Li X, Karunadharma P, Martinez G, Fallahi M, Soden J, Freeth J, Beerli RR, Grawunder U, Hudecek M, Rader C. Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility. Journal of Molecular Biology. PMID 28818634 DOI: 10.1016/j.jmb.2017.08.003  1
2017 Weber J, Peng H, Rader C. From rabbit antibody repertoires to rabbit monoclonal antibodies. Experimental & Molecular Medicine. 49: e305. PMID 28336958 DOI: 10.1038/emm.2017.23  1
2017 Li X, Nelson CG, Nair RR, Hazlehurst L, Moroni T, Martinez-Acedo P, Nanna AR, Hymel D, Burke TR, Rader C. Stable and Potent Selenomab-Drug Conjugates. Cell Chemical Biology. PMID 28330604 DOI: 10.1016/j.chembiol.2017.02.012  1
2017 Li X, Rader C. Utilization of Selenocysteine for Site-Specific Antibody Conjugation. Methods in Molecular Biology (Clifton, N.J.). 1575: 145-164. PMID 28255878 DOI: 10.1007/978-1-4939-6857-2_8  1
2016 Yan X, Ge H, Huang T, Hindra, Yang D, Teng Q, Crnovčić I, Li X, Rudolf JD, Lohman JR, Gansemans Y, Zhu X, Huang Y, Zhao LX, Jiang Y, ... ... Rader C, et al. Strain Prioritization and Genome Mining for Enediyne Natural Products. Mbio. 7. PMID 27999165 DOI: 10.1128/mBio.02104-16  1
2016 Patterson JT, Wilson HD, Asano S, Nilchan N, Fuller RP, Roush WR, Rader C, Barbas CF. Human Serum Albumin Domain I Fusion Protein for Antibody Conjugation. Bioconjugate Chemistry. PMID 27666414 DOI: 10.1021/acs.bioconjchem.6b00432  1
2016 Gnaim S, Scomparin A, Li X, Baran PS, Rader C, Satchi-Fainaro R, Shabat D. Tagging the Untaggable: A Difluoroalkyl-Sulfinate Ketone-Based Reagent for Direct C-H Functionalization of Bioactive Heteroarenes. Bioconjugate Chemistry. PMID 27494153 DOI: 10.1021/acs.bioconjchem.6b00382  1
2016 Walseng E, Nelson CG, Qi J, Nanna AR, Roush WR, Goswami RK, Sinha SC, Burke TR, Rader C. Chemically programmed bispecific antibodies in diabody format. The Journal of Biological Chemistry. PMID 27445334 DOI: 10.1074/jbc.M116.745588  0.92
2016 Pedzisa L, Li X, Rader C, Roush WR. Assessment of reagents for selenocysteine conjugation and the stability of selenocysteine adducts. Organic & Biomolecular Chemistry. PMID 27184239 DOI: 10.1039/c6ob00775a  1
2016 Li W, Li X, Huang T, Teng Q, Crnovcic I, Rader C, Shen B. Engineered production of cancer targeting peptide (CTP)-containing C-1027 in Streptomyces globisporus and biological evaluation. Bioorganic & Medicinal Chemistry. PMID 27094150 DOI: 10.1016/j.bmc.2016.04.017  1
2016 Sarkar M, Liu Y, Qi J, Peng H, Morimoto J, Rader C, Chiorazzi N, Kodadek T. Targeting stereotyped B cell receptors from chronic lymphocytic leukemia patients with synthetic antigen surrogates. The Journal of Biological Chemistry. PMID 26851280 DOI: 10.1074/jbc.M115.701656  0.92
2015 Ma M, Rateb ME, Teng Q, Yang D, Rudolf JD, Zhu X, Huang Y, Zhao LX, Jiang Y, Li X, Rader C, Duan Y, Shen B. Angucyclines and Angucyclinones from Streptomyces sp. CB01913 Featuring C-Ring Cleavage and Expansion. Journal of Natural Products. PMID 26335269 DOI: 10.1021/acs.jnatprod.5b00601  0.92
2015 Bohndorf K, Beckmann J, Jäger M, Kenn W, Maus U, Nöth U, Peters KM, Rader C, Reppenhagen S, Roth A. [S3 Guideline. Part 1: Diagnosis and Differential Diagnosis of Non-Traumatic Adult Femoral Head Necrosis]. Zeitschrift FüR OrthopäDie Und Unfallchirurgie. 153: 375-86. PMID 26274557 DOI: 10.1055/s-0035-1545901  0.64
2015 Roth A, Beckmann J, Smolenski U, Fischer A, Jäger M, Tingart M, Rader C, Peters KM, Reppenhagen S, Nöth U, Heiss C, Maus U. [S3 guideline. Part 2: Non-Traumatic Avascular Femoral Head Necrosis in Adults - Untreated Course and Conservative Treatment]. Zeitschrift Fur Orthopadie Und Unfallchirurgie. PMID 26244940 DOI: 10.1055/s-0035-1545903  0.64
2015 Maus U, Roth A, Tingart M, Rader C, Jäger M, Nöth U, Reppenhagen S, Heiss C, Beckmann J. [S3 Guideline. Part 3: Non-Traumatic Avascular Necrosis in Adults - Surgical Treatment of Atraumatic Avascular Femoral Head Necrosis in Adults]. Zeitschrift Fur Orthopadie Und Unfallchirurgie. PMID 26244939 DOI: 10.1055/s-0035-1545902  0.64
2015 Huang X, Park H, Greene J, Pao J, Mulvey E, Zhou SX, Albert CM, Moy F, Sachdev D, Yee D, Rader C, Hamby CV, Loeb DM, Cairo MS, Zhou X. IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas. Plos One. 10: e0133152. PMID 26173023 DOI: 10.1371/journal.pone.0133152  0.92
2015 Li X, Patterson JT, Sarkar M, Pedzisa L, Kodadek T, Roush WR, Rader C. Site-Specific Dual Antibody Conjugation via Engineered Cysteine and Selenocysteine Residues. Bioconjugate Chemistry. PMID 26161903 DOI: 10.1021/acs.bioconjchem.5b00244  0.92
2015 Mani R, Chiang CL, Frissora FW, Yan R, Mo X, Baskar S, Rader C, Klisovic R, Phelps MA, Chen CS, Lee RJ, Byrd JC, Baiocchi R, Lee LJ, Muthusamy N. ROR1-targeted delivery of OSU-2S, a nonimmunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle-cell lymphoma in vitro and in vivo. Experimental Hematology. PMID 25937048 DOI: 10.1016/j.exphem.2015.04.008  0.92
2015 Chinthalapudi K, Patil DN, Rangarajan ES, Rader C, Izard T. Lipid-directed vinculin dimerization. Biochemistry. 54: 2758-68. PMID 25880222 DOI: 10.1021/acs.biochem.5b00015  0.92
2015 Rader C. Chemical biology: How to minimalize antibodies. Nature. 518: 38-9. PMID 25652990 DOI: 10.1038/518038a  0.92
2015 Berger C, Sommermeyer D, Hudecek M, Berger M, Balakrishnan A, Paszkiewicz PJ, Kosasih PL, Rader C, Riddell SR. Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells. Cancer Immunology Research. 3: 206-16. PMID 25355068 DOI: 10.1158/2326-6066.CIR-14-0163  0.92
2015 Hudecek M, Sommermeyer D, Kosasih PL, Silva-Benedict A, Liu L, Rader C, Jensen MC, Riddell SR. The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity. Cancer Immunology Research. 3: 125-35. PMID 25212991 DOI: 10.1158/2326-6066.CIR-14-0127  0.92
2015 Mani R, Mao Y, Frissora FW, Chiang CL, Wang J, Zhao Y, Wu Y, Yu B, Yan R, Mo X, Yu L, Flynn J, Jones J, Andritsos L, Baskar S, ... Rader C, et al. Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia. Leukemia. 29: 346-55. PMID 24947019 DOI: 10.1038/leu.2014.199  0.92
2015 Rader CP, Corsten N, Rolf O. Osteomalacia and vitamin D deficiency | Osteomalazie und Vitamin-D-Hypovitaminose Orthopade. DOI: 10.1007/s00132-015-3141-9  0.64
2014 Sarkar M, Liu Y, Morimoto J, Peng H, Aquino C, Rader C, Chiorazzi N, Kodadek T. Recognition of antigen-specific B-cell receptors from chronic lymphocytic leukemia patients by synthetic antigen surrogates. Chemistry & Biology. 21: 1670-9. PMID 25467125 DOI: 10.1016/j.chembiol.2014.10.010  0.92
2014 Vire B, Skarzynski M, Thomas JD, Nelson CG, David A, Aue G, Burke TR, Rader C, Wiestner A. Harnessing the fcμ receptor for potent and selective cytotoxic therapy of chronic lymphocytic leukemia. Cancer Research. 74: 7510-20. PMID 25344228 DOI: 10.1158/0008-5472.CAN-14-2030  0.92
2014 Rader C, Segal DJ, Shabat D. Carlos F. Barbas III (1964-2014): Visionary at the interface of chemistry and biology. Acs Chemical Biology. 9: 1645-6. PMID 25123302 DOI: 10.1021/cb5005993  0.92
2014 Patterson JT, Asano S, Li X, Rader C, Barbas CF. Improving the serum stability of site-specific antibody conjugates with sulfone linkers. Bioconjugate Chemistry. 25: 1402-7. PMID 25099687 DOI: 10.1021/bc500276m  0.92
2014 Grönwall C, Charles ED, Dustin LB, Rader C, Silverman GJ. Selection of apoptotic cell specific human antibodies from adult bone marrow. Plos One. 9: e95999. PMID 24760047 DOI: 10.1371/journal.pone.0095999  0.92
2014 Rader C. Chemically programmed antibodies. Trends in Biotechnology. 32: 186-97. PMID 24630478 DOI: 10.1016/j.tibtech.2014.02.003  0.92
2014 Li X, Yang J, Rader C. Antibody conjugation via one and two C-terminal selenocysteines. Methods (San Diego, Calif.). 65: 133-8. PMID 23756202 DOI: 10.1016/j.ymeth.2013.05.023  0.92
2013 Stoeckli ET, Kilinc D, Kunz B, Kunz S, Lee GU, Martines E, Rader C, Suter D. Analysis of cell-cell contact mediated by Ig superfamily cell adhesion molecules. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. 61: 9.5.1-9.5.85. PMID 24510806 DOI: 10.1002/0471143030.cb0905s61  0.64
2013 Hudecek M, Lupo-Stanghellini MT, Kosasih PL, Sommermeyer D, Jensen MC, Rader C, Riddell SR. Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3153-64. PMID 23620405 DOI: 10.1158/1078-0432.CCR-13-0330  0.92
2012 Dave H, Anver MR, Butcher DO, Brown P, Khan J, Wayne AS, Baskar S, Rader C. Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies. Plos One. 7: e52655. PMID 23285131 DOI: 10.1371/journal.pone.0052655  0.92
2012 Thomas JD, Cui H, North PJ, Hofer T, Rader C, Burke TR. Application of strain-promoted azide-alkyne cycloaddition and tetrazine ligation to targeted Fc-drug conjugates. Bioconjugate Chemistry. 23: 2007-13. PMID 22988967 DOI: 10.1021/bc300052u  0.92
2012 Cui H, Thomas JD, Burke TR, Rader C. Chemically programmed bispecific antibodies that recruit and activate T cells. The Journal of Biological Chemistry. 287: 28206-14. PMID 22761439 DOI: 10.1074/jbc.M112.384594  0.92
2012 Yang J, Rader C. Cloning, expression, and purification of monoclonal antibodies in scFv-Fc format. Methods in Molecular Biology (Clifton, N.J.). 901: 209-32. PMID 22723104 DOI: 10.1007/978-1-61779-931-0_14  0.92
2012 Rader C. Selection of human Fab libraries by phage display. Methods in Molecular Biology (Clifton, N.J.). 901: 81-99. PMID 22723095 DOI: 10.1007/978-1-61779-931-0_5  0.92
2012 Rader C. Generation of human Fab libraries for phage display. Methods in Molecular Biology (Clifton, N.J.). 901: 53-79. PMID 22723094 DOI: 10.1007/978-1-61779-931-0_4  0.92
2012 Baskar S, Wiestner A, Wilson WH, Pastan I, Rader C. Targeting malignant B cells with an immunotoxin against ROR1. Mabs. 4: 349-61. PMID 22531447 DOI: 10.4161/mabs.19870  0.92
2012 Rader CP, Baumann B. Update etiology and risk factors in osteonecrosis and osteonecrosis and steroids | Update ätiologie/risikofaktoren bei osteonekrosen und osteonekrose bei kortikoidtherapie Osteologie. 21: 269-273.  0.64
2011 Andris-Widhopf J, Steinberger P, Fuller R, Rader C, Barbas CF. Generation of human Fab antibody libraries: PCR amplification and assembly of light- and heavy-chain coding sequences. Cold Spring Harbor Protocols. 2011. PMID 21880817 DOI: 10.1101/pdb.prot065565  0.92
2011 Andris-Widhopf J, Steinberger P, Fuller R, Rader C, Barbas CF. Generation of human scFv antibody libraries: PCR amplification and assembly of light- and heavy-chain coding sequences. Cold Spring Harbor Protocols. 2011. PMID 21880816 DOI: 10.1101/pdb.prot065573  0.92
2011 Yang J, Baskar S, Kwong KY, Kennedy MG, Wiestner A, Rader C. Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies. Plos One. 6: e21018. PMID 21698301 DOI: 10.1371/journal.pone.0021018  0.92
2011 Rader C. DARTs take aim at BiTEs. Blood. 117: 4403-4. PMID 21527536 DOI: 10.1182/blood-2011-02-337691  0.92
2011 Bagnara D, Kaufman MS, Calissano C, Marsilio S, Patten PE, Simone R, Chum P, Yan XJ, Allen SL, Kolitz JE, Baskar S, Rader C, Mellstedt H, Rabbani H, Lee A, et al. A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Blood. 117: 5463-72. PMID 21385850 DOI: 10.1182/blood-2010-12-324210  0.92
2011 Pérez-Galán P, Mora-Jensen H, Weniger MA, Shaffer AL, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P, Raghavachari N, Stetler-Stevenson M, Yuan C, Pittaluga S, Maric I, et al. Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation. Blood. 117: 542-52. PMID 20956803 DOI: 10.1182/blood-2010-02-269514  0.92
2011 Ho M, Feng M, Fisher RJ, Rader C, Pastan I. A novel high-affinity human monoclonal antibody to mesothelin. International Journal of Cancer. Journal International Du Cancer. 128: 2020-30. PMID 20635390 DOI: 10.1002/ijc.25557  0.92
2011 Rader C. Monoclonal antibody therapy for cancer Experimental and Applied Immunotherapy. 59-83. DOI: 10.1007/978-1-60761-980-2_3  0.92
2010 Salerno E, Yuan Y, Scaglione BJ, Marti G, Jankovic A, Mazzella F, Laurindo MF, Despres D, Baskar S, Rader C, Raveche E. The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia. Cytometry. Part B, Clinical Cytometry. 78: S98-109. PMID 20839343 DOI: 10.1002/cyto.b.20544  0.92
2010 Hudecek M, Schmitt TM, Baskar S, Lupo-Stanghellini MT, Nishida T, Yamamoto TN, Bleakley M, Turtle CJ, Chang WC, Greisman HA, Wood B, Maloney DG, Jensen MC, Rader C, Riddell SR. The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor. Blood. 116: 4532-41. PMID 20702778 DOI: 10.1182/blood-2010-05-283309  0.92
2010 Beerli RR, Rader C. Mining human antibody repertoires. Mabs. 2: 365-78. PMID 20505349  0.92
2010 DiMattia MA, Watts NR, Stahl SJ, Rader C, Wingfield PT, Stuart DI, Steven AC, Grimes JM. Implications of the HIV-1 Rev dimer structure at 3.2 A resolution for multimeric binding to the Rev response element. Proceedings of the National Academy of Sciences of the United States of America. 107: 5810-4. PMID 20231488 DOI: 10.1073/pnas.0914946107  0.92
2010 Stahl SJ, Watts NR, Rader C, DiMattia MA, Mage RG, Palmer I, Kaufman JD, Grimes JM, Stuart DI, Steven AC, Wingfield PT. Generation and characterization of a chimeric rabbit/human Fab for co-crystallization of HIV-1 Rev. Journal of Molecular Biology. 397: 697-708. PMID 20138059 DOI: 10.1016/j.jmb.2010.01.061  0.92
2010 Lapalombella R, Andritsos L, Liu Q, May SE, Browning R, Pham LV, Blum KA, Blum W, Ramanunni A, Raymond CA, Smith LL, Lehman A, Mo X, Jarjoura D, Chen CS, ... ... Rader C, et al. Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway. Blood. 115: 2619-29. PMID 19965642 DOI: 10.1182/blood-2009-09-242438  0.92
2010 Roth A, Jäger M, Maus U, Peters KM, Rader C, Reppenhagen S, Tingart M, Kopp I. Atraumatic femoral head necrosis - Evidence is required to create current guidelines | Atraumatische femurkopfnekrose des erwachsenen - Evidenz als voraussetzung für die erstellung aktueller leitlinien Osteologie. 19: 60-64.  0.64
2010 Rader CP, Beckmann J, Tingart M. The Transient Bone Marrow Edema Syndrom as a differential diagnosis of femoral head necrosis at an early stage | Das transiente Knochenmarködemsyndrom als differenzialdiagnose der atraumatischen femurkopfnekrose im frühen stadium Osteologie. 19: 24-28.  0.64
2010 Beckmann J, Rader C, Lüring C, Rath B, Grifka J, Tingart M. Endoprosthesis in femoral head necrosis | Endoprothetische gelenkversorgung bei hüftkopfnekrose Osteologie. 19: 46-52.  0.64
2009 Hofer T, Skeffington LR, Chapman CM, Rader C. Molecularly defined antibody conjugation through a selenocysteine interface. Biochemistry. 48: 12047-57. PMID 19894757 DOI: 10.1021/bi901744t  0.92
2009 Baskar S, Suschak JM, Samija I, Srinivasan R, Childs RW, Pavletic SZ, Bishop MR, Rader C. A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display. Blood. 114: 4494-502. PMID 19667400 DOI: 10.1182/blood-2009-05-222786  0.92
2009 Robak LA, Venkatesh K, Lee H, Raiker SJ, Duan Y, Lee-Osbourne J, Hofer T, Mage RG, Rader C, Giger RJ. Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 5768-83. PMID 19420245 DOI: 10.1523/JNEUROSCI.4935-08.2009  0.92
2009 Derfuss T, Parikh K, Velhin S, Braun M, Mathey E, Krumbholz M, Kümpfel T, Moldenhauer A, Rader C, Sonderegger P, Pöllmann W, Tiefenthaller C, Bauer J, Lassmann H, Wekerle H, et al. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proceedings of the National Academy of Sciences of the United States of America. 106: 8302-7. PMID 19416878 DOI: 10.1073/pnas.0901496106  0.64
2009 Rader C. Generation and selection of rabbit antibody libraries by phage display. Methods in Molecular Biology (Clifton, N.J.). 525: 101-28, xiv. PMID 19252834 DOI: 10.1007/978-1-59745-554-1_5  0.92
2009 Rader C. Overview on concepts and applications of Fab antibody fragments. Current Protocols in Protein Science / Editorial Board, John E. Coligan ... [Et Al.]. Unit 6.9. PMID 19235140 DOI: 10.1002/0471140864.ps0609s55  0.92
2009 Kwong KY, Rader C. E. coli expression and purification of Fab antibody fragments. Current Protocols in Protein Science / Editorial Board, John E. Coligan ... [Et Al.]. Unit 6.10. PMID 19235139 DOI: 10.1002/0471140864.ps0610s55  0.92
2008 Thomas JD, Hofer T, Rader C, Burke TR. Application of a trifunctional reactive linker for the construction of antibody-drug hybrid conjugates. Bioorganic & Medicinal Chemistry Letters. 18: 5785-8. PMID 18922692 DOI: 10.1016/j.bmcl.2008.09.078  0.92
2008 Giger RJ, Venkatesh K, Chivatakarn O, Raiker SJ, Robak L, Hofer T, Lee H, Rader C. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems. Restorative Neurology and Neuroscience. 26: 97-115. PMID 18820405  0.92
2008 Kwong KY, Baskar S, Zhang H, Mackall CL, Rader C. Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity. Journal of Molecular Biology. 384: 1143-56. PMID 18809410 DOI: 10.1016/j.jmb.2008.09.008  0.92
2008 Hofer T, Thomas JD, Burke TR, Rader C. An engineered selenocysteine defines a unique class of antibody derivatives. Proceedings of the National Academy of Sciences of the United States of America. 105: 12451-6. PMID 18719095 DOI: 10.1073/pnas.0800800105  0.92
2008 Baskar S, Kwong KY, Hofer T, Levy JM, Kennedy MG, Lee E, Staudt LM, Wilson WH, Wiestner A, Rader C. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 396-404. PMID 18223214 DOI: 10.1158/1078-0432.CCR-07-1823  0.92
2008 Rader C, Bishop MR. Monoclonal antibodies in cancer therapy General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology. 453-484. DOI: 10.1007/978-1-4020-6087-8_20  0.92
2007 Baumann B, Hendrich C, Barthel T, Bockholt M, Walther M, Eulert J, Rader CP. 9- to 11-year results of cemented titanium mueller straight stem in total hip arthroplasty. Orthopedics. 30: 551-7. PMID 17672155  0.64
2007 Rader CP. [Standards and perspectives for thromboembolism prophylaxis]. Der OrthopäDe. 36: 560, 562-6. PMID 17546440 DOI: 10.1007/s00132-007-1105-4  0.64
2007 Rader CP. [Transient osteoporosis and osteonecrosis of the femoral head. Risk factors, classification and differential diagnosis]. Der OrthopäDe. 36: 423-4, 426-9. PMID 17479249 DOI: 10.1007/s00132-007-1082-7  0.64
2007 Baumann B, Seufert J, Rolf O, Jakob F, Goebel S, Eulert J, Rader CP. Upregulation of LITAF mRNA expression upon exposure to TiAlV and polyethylene wear particles in THP-1 macrophages. Biomedizinische Technik. Biomedical Engineering. 52: 200-7. PMID 17408380 DOI: 10.1515/BMT.2007.037  0.64
2007 Abraham S, Guo F, Li LS, Rader C, Liu C, Barbas CF, Lerner RA, Sinha SC. Synthesis of the next-generation therapeutic antibodies that combine cell targeting and antibody-catalyzed prodrug activation. Proceedings of the National Academy of Sciences of the United States of America. 104: 5584-9. PMID 17372220 DOI: 10.1073/pnas.0700223104  0.92
2007 Hofer T, Tangkeangsirisin W, Kennedy MG, Mage RG, Raiker SJ, Venkatesh K, Lee H, Giger RJ, Rader C. Chimeric rabbit/human Fab and IgG specific for members of the Nogo-66 receptor family selected for species cross-reactivity with an improved phage display vector. Journal of Immunological Methods. 318: 75-87. PMID 17140598 DOI: 10.1016/j.jim.2006.10.007  0.92
2006 Baumann B, Rolf O, Jakob F, Goebel S, Sterner T, Eulert J, Rader CP. Synergistic effects of mixed TiAlV and polyethylene wear particles on TNFalpha response in THP-1 macrophages. Biomedizinische Technik. Biomedical Engineering. 51: 360-6. PMID 17155873 DOI: 10.1515/BMT.2006.070  0.64
2006 Morawietz L, Classen RA, Schröder JH, Dynybil C, Perka C, Skwara A, Neidel J, Gehrke T, Frommelt L, Hansen T, Otto M, Barden B, Aigner T, Stiehl P, Schubert T, ... ... Rader CP, et al. Proposal for a histopathological consensus classification of the periprosthetic interface membrane. Journal of Clinical Pathology. 59: 591-7. PMID 16731601 DOI: 10.1136/jcp.2005.027458  0.64
2006 Jendreyko N, Rader C, Barbas CF, Gaedicke G. Simultaneous, phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody enhances antiangiogenic effects in vivo. Klinische PäDiatrie. 218: 143-51. PMID 16688670 DOI: 10.1055/s-2006-933415  0.92
2006 Popkov M, Rader C, Gonzalez B, Sinha SC, Barbas CF. Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector. International Journal of Cancer. Journal International Du Cancer. 119: 1194-207. PMID 16570283 DOI: 10.1002/ijc.21924  0.92
2006 Rader C, Barbas CF. Synthetic antibodies prey on B cells Blood. 108: 2889-2890. DOI: 10.1182/blood-2006-08-041327  0.92
2005 Nathan S, Rader C, Barbas CF. Neutralization of Burkholderia pseudomallei protease by Fabs generated through phage display. Bioscience, Biotechnology, and Biochemistry. 69: 2302-11. PMID 16377887 DOI: 10.1271/bbb.69.2302  0.92
2005 Jendreyko N, Popkov M, Rader C, Barbas CF. Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivo. Proceedings of the National Academy of Sciences of the United States of America. 102: 8293-8. PMID 15928093 DOI: 10.1073/pnas.0503168102  0.92
2005 Baumann B, Seufert J, Jakob F, Nöth U, Rolf O, Eulert J, Rader CP. Activation of NF-kappaB signalling and TNFalpha-expression in THP-1 macrophages by TiAlV- and polyethylene-wear particles. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 23: 1241-8. PMID 15913942 DOI: 10.1016/j.orthres.2005.02.017.1100230602  0.64
2005 Rolf O, Baumann B, Sterner T, Schütze N, Jakob F, Eulert J, Rader CP. Characterization of mode II-wear particles and cytokine response in a human macrophage-like cell culture. Biomedizinische Technik. Biomedical Engineering. 50: 25-9. PMID 15792198 DOI: 10.1515/BMT.2005.005  0.64
2005 Popkov M, Jendreyko N, McGavern DB, Rader C, Barbas CF. Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody. Cancer Research. 65: 972-81. PMID 15705898  0.92
2005 Hendrich C, Sauer U, Albrecht T, Rader CP. Subsidence of titanium straight stems in combination with highly viscous bone cement. International Orthopaedics. 29: 96-100. PMID 15703935 DOI: 10.1007/s00264-004-0631-5  0.64
2005 Venkatesh K, Chivatakarn O, Lee H, Joshi PS, Kantor DB, Newman BA, Mage R, Rader C, Giger RJ. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 808-22. PMID 15673660 DOI: 10.1523/JNEUROSCI.4464-04.2005  0.92
2004 Sterner T, Schütze N, Saxler G, Jakob F, Rader CP. [Effects of clinically relevant alumina ceramic, zirconia ceramic and titanium particles of different sizes and concentrations on TNF-alpha release in a human macrophage cell line]. Biomedizinische Technik. Biomedical Engineering. 49: 340-4. PMID 15655926 DOI: 10.1515/BMT.2004.063  0.64
2004 Li LS, Rader C, Matsushita M, Das S, Barbas CF, Lerner RA, Sinha SC. Chemical adaptor immunotherapy: design, synthesis, and evaluation of novel integrin-targeting devices. Journal of Medicinal Chemistry. 47: 5630-40. PMID 15509162 DOI: 10.1021/jm049666k  0.92
2004 Sinha SC, Li LS, Watanabe S, Kaltgrad E, Tanaka F, Rader C, Lerner RA, Barbas CF. Aldolase antibody activation of prodrugs of potent aldehyde-containing cytotoxics for selective chemotherapy. Chemistry (Weinheim An Der Bergstrasse, Germany). 10: 5467-72. PMID 15378729 DOI: 10.1002/chem.200400419  0.92
2004 Popkov M, Rader C, Barbas CF. Isolation of human prostate cancer cell reactive antibodies using phage display technology. Journal of Immunological Methods. 291: 137-51. PMID 15345312 DOI: 10.1016/j.jim.2004.05.004  0.92
2004 Baumann B, Rader CP, Seufert J, Nöth U, Rolf O, Eulert J, Jakob F. Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA. Acta Orthopaedica Scandinavica. 75: 295-302. PMID 15260421 DOI: 10.1080/00016470410001222  0.64
2004 Hendrich C, Ak D, Sauer U, Kirschner S, Rader CP. [Long-term results of uncemented Parhofer-Mönch screw rings]. Zeitschrift FüR OrthopäDie Und Ihre Grenzgebiete. 142: 292-7. PMID 15250000 DOI: 10.1055/s-2004-818784  0.64
2004 Radke S, Kirschner S, Seipel V, Rader C, Eulert J. Magnetic resonance imaging criteria of successful core decompression in avascular necrosis of the hip. Skeletal Radiology. 33: 519-23. PMID 15221216 DOI: 10.1007/s00256-004-0811-9  0.64
2004 Popkov M, Jendreyko N, Gonzalez-Sapienza G, Mage RG, Rader C, Barbas CF. Human/mouse cross-reactive anti-VEGF receptor 2 recombinant antibodies selected from an immune b9 allotype rabbit antibody library. Journal of Immunological Methods. 288: 149-64. PMID 15183093 DOI: 10.1016/j.jim.2004.03.005  0.92
2004 Gopin A, Rader C, Shabat D. New chemical adaptor unit designed to release a drug from a tumor targeting device by enzymatic triggering. Bioorganic & Medicinal Chemistry. 12: 1853-8. PMID 15051054 DOI: 10.1016/j.bmc.2004.01.041  0.92
2004 Sinha SC, Li LS, Miller GP, Dutta S, Rader C, Lerner RA. Prodrugs of dynemicin analogs for selective chemotherapy mediated by an aldolase catalytic Ab. Proceedings of the National Academy of Sciences of the United States of America. 101: 3095-9. PMID 14981258 DOI: 10.1073/pnas.0307319101  0.92
2004 Chung J, Rader C, Popkov M, Hur YM, Kim HK, Lee YJ, Barbas CF. Integrin alphaIIbbeta3-specific synthetic human monoclonal antibodies and HCDR3 peptides that potently inhibit platelet aggregation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 361-3. PMID 14688205 DOI: 10.1096/fj.03-0586fje  0.92
2003 Rader C, Turner JM, Heine A, Shabat D, Sinha SC, Wilson IA, Lerner RA, Barbas CF. A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy. Journal of Molecular Biology. 332: 889-99. PMID 12972259 DOI: 10.1016/S0022-2836(03)00992-6  0.92
2003 Jendreyko N, Popkov M, Beerli RR, Chung J, McGavern DB, Rader C, Barbas CF. Intradiabodies, bispecific, tetravalent antibodies for the simultaneous functional knockout of two cell surface receptors. The Journal of Biological Chemistry. 278: 47812-9. PMID 12947084 DOI: 10.1074/jbc.M307002200  0.92
2003 Radke S, Kirschner S, Seipel V, Rader C, Eulert J. Treatment of transient bone marrow oedema of the hip--a comparative study. International Orthopaedics. 27: 149-52. PMID 12799758 DOI: 10.1007/s00264-003-0452-y  0.64
2003 Radke S, Rader C, Kenn W, Kirschner S, Walther M, Eulert J. Transient marrow edema syndrome of the hip: results after core decompression. A prospective MRI-controlled study in 22 patients. Archives of Orthopaedic and Trauma Surgery. 123: 223-7. PMID 12739033 DOI: 10.1007/s00402-003-0506-z  0.64
2003 Rader C, Sinha SC, Popkov M, Lerner RA, Barbas CF. Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalyst. Proceedings of the National Academy of Sciences of the United States of America. 100: 5396-400. PMID 12702756 DOI: 10.1073/pnas.0931308100  0.92
2003 Gopin A, Pessah N, Shamis M, Rader C, Shabat D. A chemical adaptor system designed to link a tumor-targeting device with a prodrug and an enzymatic trigger. Angewandte Chemie (International Ed. in English). 42: 327-32. PMID 12548691 DOI: 10.1002/anie.200390108  0.92
2003 Popkov M, Mage RG, Alexander CB, Thundivalappil S, Barbas CF, Rader C. Rabbit immune repertoires as sources for therapeutic monoclonal antibodies: the impact of kappa allotype-correlated variation in cysteine content on antibody libraries selected by phage display. Journal of Molecular Biology. 325: 325-35. PMID 12488098 DOI: 10.1016/S0022-2836(02)01232-9  0.92
2002 Rader C, Popkov M, Neves JA, Barbas CF. Integrin alpha(v)beta3 targeted therapy for Kaposi's sarcoma with an in vitro evolved antibody. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 2000-2. PMID 12397091 DOI: 10.1096/fj.02-0281fje  0.92
2002 Hendrich C, Nöth U, Stahl U, Merklein F, Rader CP, Schütze N, Thull R, Tuan RS, Eulert J. Testing of skeletal implant surfaces with human fetal osteoblasts. Clinical Orthopaedics and Related Research. 278-89. PMID 11795745  0.64
2002 Kunz B, Lierheimer R, Rader C, Spirig M, Ziegler U, Sonderegger P. Axonin-1/TAG-1 mediates cell-cell adhesion by a cis-assisted trans-interaction. The Journal of Biological Chemistry. 277: 4551-7. PMID 11733523 DOI: 10.1074/jbc.M109779200  0.64
2001 Sonderegger P, Kunz S, Rader C, Suter DM, Stoeckli ET. Analysis of cell-cell contact mediated by Ig superfamily cell adhesion molecules. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. Unit 9.5. PMID 18228394 DOI: 10.1002/0471143030.cb0905s11  0.64
2001 Plagge A, Sendtner-Voelderndorff L, Sirim P, Freigang J, Rader C, Sonderegger P, Brümmendorf T. The contactin-related protein FAR-2 defines purkinje cell clusters and labels subpopulations of climbing fibers in the developing cerebellum. Molecular and Cellular Neurosciences. 18: 91-107. PMID 11461156 DOI: 10.1006/mcne.2001.1006  0.64
2001 Shabat D, Lode HN, Pertl U, Reisfeld RA, Rader C, Lerner RA, Barbas CF. In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy. Proceedings of the National Academy of Sciences of the United States of America. 98: 7528-33. PMID 11404472 DOI: 10.1073/pnas.131187998  0.92
2001 Rader C. Antibody libraries in drug and target discovery Drug Discovery Today. 6: 36-43. DOI: 10.1016/S1359-6446(00)01595-6  0.92
2000 Steinert A, Hendrich C, Merklein F, Rader CP, Schütze N, Thull R, Eulert J. [Standardized testing of bone implant surfaces with an osteoblast cell culture cyste. III. PVD hard coatings and Ti6Al4V]. Biomedizinische Technik. Biomedical Engineering. 45: 349-55. PMID 11194641  0.64
2000 Rader CP, Hendrich C, Löw S, Walther M, Eulert J. [5- to 8-year results of total hip endoprosthesis implantation with the Müller straight shaft prosthesis (cemented TiAlNb shaft)]. Der Unfallchirurg. 103: 846-52. PMID 11098744 DOI: 10.1007/s001130050631  0.64
2000 Barbas CF, Rader C, Segal DJ, List B, Turner JM. From catalytic asymmetric synthesis to the transcriptional regulation of genes: in vivo and in vitro evolution of proteins. Advances in Protein Chemistry. 55: 317-66. PMID 11050938  0.92
2000 Wölfel AR, Walther M, Rader C, Beck H. [Endoprosthetic management of patients with hip arthrodesis]. Zeitschrift FüR OrthopäDie Und Ihre Grenzgebiete. 138: 318-23. PMID 11033899 DOI: 10.1055/s-2000-10155  0.64
2000 Altvater T, Hendrich C, Nöth U, Rader CP, Stach R, Schütze N, Eulert J, Thull R. [Cytotoxicity study of high gold content Degutan surfaces of various degrees of roughness with fibroblasts (BALB 3T3) and osteoblasts (hFOB 1.19)]. Biomedizinische Technik. Biomedical Engineering. 45: 238-42. PMID 11030093  0.64
2000 Andris-Widhopf J, Rader C, Steinberger P, Fuller R, Barbas CF. Methods for the generation of chicken monoclonal antibody fragments by phage display. Journal of Immunological Methods. 242: 159-81. PMID 10986398 DOI: 10.1016/S0022-1759(00)00221-0  0.92
2000 Grossmann R, Taleghani BM, Rader C, Kramer C, Eulert J, Keller F. Is there any influence of the protein C system on perioperative blood loss in total knee or hip arthroplasty? Thrombosis Research. 99: 473-5. PMID 10973676 DOI: 10.1016/S0049-3848(00)00275-9  0.64
2000 Steinberger P, Sutton JK, Rader C, Elia M, Barbas CF. Generation and characterization of a recombinant human CCR5-specific antibody. A phage display approach for rabbit antibody humanization. The Journal of Biological Chemistry. 275: 36073-8. PMID 10969070 DOI: 10.1074/jbc.M002765200  0.92
2000 Rader C, List B. Catalytic antibodies as magic bullets. Chemistry (Weinheim An Der Bergstrasse, Germany). 6: 2091-5. PMID 10926212 DOI: 10.1002/1521-3765(20000616)6:12<2091::AID-CHEM2091>3.0.CO;2-S  0.92
2000 Fitzli D, Stoeckli ET, Kunz S, Siribour K, Rader C, Kunz B, Kozlov SV, Buchstaller A, Lane RP, Suter DM, Dreyer WJ, Sonderegger P. A direct interaction of axonin-1 with NgCAM-related cell adhesion molecule (NrCAM) results in guidance, but not growth of commissural axons. The Journal of Cell Biology. 149: 951-68. PMID 10811834 DOI: 10.1083/jcb.149.4.951  0.64
2000 Rader C, Ritter G, Nathan S, Elia M, Gout I, Jungbluth AA, Cohen LS, Welt S, Old LJ, Barbas CF. The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies. The Journal of Biological Chemistry. 275: 13668-76. PMID 10788485 DOI: 10.1074/jbc.275.18.13668  0.92
2000 Karlstrom A, Zhong G, Rader C, Larsen NA, Heine A, Fuller R, List B, Tanaka F, Wilson IA, Barbas CF, Lerner RA. Using antibody catalysis to study the outcome of multiple evolutionary trials of a chemical task. Proceedings of the National Academy of Sciences of the United States of America. 97: 3878-83. PMID 10760259 DOI: 10.1073/pnas.97.8.3878  0.92
1999 Rader CP, Sterner T, Jakob F, Schütze N, Eulert J. Cytokine response of human macrophage-like cells after contact with polyethylene and pure titanium particles. The Journal of Arthroplasty. 14: 840-8. PMID 10537260 DOI: 10.1016/S0883-5403(99)90035-9  0.64
1999 Shabat D, Rader C, List B, Lerner RA, Barbas CF. Multiple event activation of a generic prodrug trigger by antibody catalysis. Proceedings of the National Academy of Sciences of the United States of America. 96: 6925-30. PMID 10359815 DOI: 10.1073/pnas.96.12.6925  0.92
1999 Nöth U, Hendrich C, Merklein F, Altvater T, Rader CP, Schütze N, Eulert J, Thull R. [Standardized testing of bone implant surfaces with an osteoblast cell culture system. II. Titanium surfaces of different degrees of roughness]. Biomedizinische Technik. Biomedical Engineering. 44: 6-11. PMID 10194879  0.64
1998 Merklein F, Hendrich C, Nöth U, Kochinki G, Rader CP, Schütze N, Thull R, Eulert J. [Standardized tests of bone implant surfaces with an osteoblast cell culture system. I. Orthopedic standard materials]. Biomedizinische Technik. Biomedical Engineering. 43: 354-9. PMID 10036800  0.64
1998 Sonderegger P, Kunz S, Rader C, Buchstaller A, Berger P, Vogt L, Kozlov SV, Ziegler U, Kunz B, Fitzli D, Stoeckli ET. Discrete clusters of axonin-1 and NgCAM at neuronal contact sites: facts and speculations on the regulation of axonal fasciculation. Progress in Brain Research. 117: 93-104. PMID 9932403  0.64
1998 Kunz S, Spirig M, Ginsburg C, Buchstaller A, Berger P, Lanz R, Rader C, Vogt L, Kunz B, Sonderegger P. Neurite fasciculation mediated by complexes of axonin-1 and Ng cell adhesion molecule. The Journal of Cell Biology. 143: 1673-90. PMID 9852159 DOI: 10.1083/jcb.143.6.1673  0.64
1998 Rader C, Cheresh DA, Barbas CF. A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries. Proceedings of the National Academy of Sciences of the United States of America. 95: 8910-5. PMID 9671778 DOI: 10.1073/pnas.95.15.8910  0.92
1998 Rader CP, Kramer C, König A, Hendrich C, Eulert J. Low-molecular-weight heparin and partial thromboplastin time-adjusted unfractionated heparin in thromboprophylaxis after total knee and total hip arthroplasty. The Journal of Arthroplasty. 13: 180-5. PMID 9526211 DOI: 10.1016/S0883-5403(98)90096-1  0.64
1997 König A, Scheidler M, Rader C, Eulert J. The need for a dual rating system in total knee arthroplasty. Clinical Orthopaedics and Related Research. 161-7. PMID 9418634  0.64
1997 Rader C, Barbas CF. Phage display of combinatorial antibody libraries. Current Opinion in Biotechnology. 8: 503-8. PMID 9265732 DOI: 10.1016/S0958-1669(97)80075-4  0.92
1997 Rader CP, Barthel T, Haase M, Scheidler M, Eulert J. Heterotopic ossification after total knee arthroplasty. 54/615 cases after 1-6 years' follow-up. Acta Orthopaedica Scandinavica. 68: 46-50. PMID 9057567  0.64
1997 Hendrich C, Bahlmann J, Rader CP, Eulen J. 298 Pfannenrevisionen mit allogener spongiosaplastik - ergebnisse der röntgenologischen wanderungsanalyse Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete. 135: A98.  0.64
1997 Hendrich C, Bahlmann J, Rader CP, Herold T, Eulen J. 167 Strukturelles autologes transplantat bei hüftdysplasie röntgenologische pfannenmigration Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete. 135: A57.  0.64
1997 Rader CP, Gomille T, Eulert J. 274 Dekompression bei der httftkopfnekrose des erwachsenen - 4 bis 18 jahre verlaufskontrolle Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete. 135: A90.  0.64
1997 Hendrich C, Rader CP, Klein G, Oswald B, Kramer C. Interpretation of digital migration analysis of uncemented PM-total hip prostheses | Interpretationsmoglichkeiten der digitalen wanderungs-analyse zementfreier PM-Hufttotalendoprothesen Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete. 135: 285-291.  0.64
1996 Rader CP, Löhr J, Wittmann R, Eulert J. Results of total knee arthroplasty with a metal-backed patellar component. A 6-year follow-up study. The Journal of Arthroplasty. 11: 923-30. PMID 8986570 DOI: 10.1016/S0883-5403(96)80133-1  0.64
1996 Buchstaller A, Kunz S, Berger P, Kunz B, Ziegler U, Rader C, Sonderegger P. Cell adhesion molecules NgCAM and axonin-1 form heterodimers in the neuronal membrane and cooperate in neurite outgrowth promotion. The Journal of Cell Biology. 135: 1593-607. PMID 8978825 DOI: 10.1083/jcb.135.6.1593  0.64
1996 Rader C, Kunz B, Lierheimer R, Giger RJ, Berger P, Tittmann P, Gross H, Sonderegger P. Implications for the domain arrangement of axonin-1 derived from the mapping of its NgCAM binding site. The Embo Journal. 15: 2056-68. PMID 8641271  0.64
1995 Giger RJ, Vogt L, Zuellig RA, Rader C, Henehan-Beatty A, Wolfer DP, Sonderegger P. The gene of chicken axonin-1. Complete structure and analysis of the promoter. European Journal of Biochemistry / Febs. 227: 617-28. PMID 7867620 DOI: 10.1111/j.1432-1033.1995.tb20181.x  0.64
1995 Rader CP, Barthel T, Hendrich C, Eulert J. [Pigmented villonodular synovitis of the knee joint--long-term follow-up and therapeutic concept]. Zentralblatt FüR Chirurgie. 120: 564-70. PMID 7676755  0.64
1993 Hasler TH, Rader C, Stoeckli ET, Zuellig RA, Sonderegger P. cDNA cloning, structural features, and eucaryotic expression of human TAG-1/axonin-1. European Journal of Biochemistry / Febs. 211: 329-39. PMID 8425542 DOI: 10.1111/j.1432-1033.1993.tb19902.x  0.64
1993 Rader C, Stoeckli ET, Ziegler U, Osterwalder T, Kunz B, Sonderegger P. Cell-cell adhesion by homophilic interaction of the neuronal recognition molecule axonin-1. European Journal of Biochemistry / Febs. 215: 133-41. PMID 8344273  0.64
1992 Zuellig RA, Rader C, Schroeder A, Kalousek MB, Von Bohlen und Halbach F, Osterwalder T, Inan C, Stoeckli ET, Affolter HU, Fritz A. The axonally secreted cell adhesion molecule, axonin-1. Primary structure, immunoglobulin-like and fibronectin-type-III-like domains and glycosyl-phosphatidylinositol anchorage. European Journal of Biochemistry / Febs. 204: 453-63. PMID 1311675  0.64
Show low-probability matches.